More about

Hepatocellular Carcinoma

News
November 14, 2023
2 min read
Save

‘Significant differences’ reported by race, ethnicity in transplant rates for MASH-HCC

‘Significant differences’ reported by race, ethnicity in transplant rates for MASH-HCC

BOSTON — Hispanic and Asian patients with metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma were less likely to undergo liver transplantation compared with other races and ethnicities, data showed.

News
November 13, 2023
1 min read
Save

Transarterial chemoembolization plus vitamin K enhances anticancer effects on HCC

Transarterial chemoembolization plus vitamin K enhances anticancer effects on HCC

BOSTON — Transarterial chemoembolization with vitamin K dosing improved anticancer outcomes of objective response and progression-free survival in patients with hepatocellular carcinoma, according to a researcher at The Liver Meeting.

News
November 13, 2023
2 min read
Save

MASH resolution without worsening fibrosis boosts 15-year survival after bariatric surgery

MASH resolution without worsening fibrosis boosts 15-year survival after bariatric surgery

BOSTON — Resolution of metabolic dysfunction-associated steatohepatitis without worsening of fibrosis was linked to long-term survival after bariatric surgery, similar to that of patients without baseline MASH, according to a presenter.

News
November 13, 2023
1 min read
Save

Durvalumab regimen extends PFS in certain patients with liver cancer

Durvalumab regimen extends PFS in certain patients with liver cancer

Durvalumab combined with transarterial chemoembolization and bevacizumab lengthened PFS among certain patients with hepatocellular carcinoma, according to the agent’s manufacturer.

News
November 13, 2023
2 min read
Save

MASH now top indication for liver transplantation in those with hepatocellular carcinoma

MASH now top indication for liver transplantation in those with hepatocellular carcinoma

BOSTON — Metabolic dysfunction-associated steatohepatitis is currently the most common indication for liver transplantation in patients with hepatocellular carcinoma, increasing from 10% in 2013 to 31% in 2022, according to a presenter.

News
October 14, 2023
4 min read
Save

#OctoberIs4Livers campaign aims to ‘turn the tide’ during Liver Cancer Awareness Month

#OctoberIs4Livers campaign aims to ‘turn the tide’ during Liver Cancer Awareness Month

Liver Cancer Awareness Month, celebrated every October, seeks to raise awareness about the third deadliest cancer in the United States, with approximately 41,000 new cases and as many as 30,000 deaths each year.

News
October 13, 2023
2 min read
Save

Antidepressant use after diagnosis may reduce liver cancer mortality

Antidepressant use after diagnosis may reduce liver cancer mortality

Postdiagnosis antidepressant use reduced mortality risk among patients with hepatocellular carcinoma, according to data published in JAMA Network Open.

News
September 13, 2023
3 min read
Save

Q&A: Causes of hepatocellular carcinoma ‘differ remarkably’ by race, ethnicity

Q&A: Causes of hepatocellular carcinoma ‘differ remarkably’ by race, ethnicity

Rates of hepatocellular carcinoma caused by alcohol-related disease and nonalcoholic fatty liver disease are on the rise, especially among Hispanic individuals, according to research in Clinical Gastroenterology and Hepatology.

News
July 20, 2023
2 min read
Save

Type 2 diabetes heightens risk for hepatic decompensation, HCC in patients with NAFLD

Type 2 diabetes heightens risk for hepatic decompensation, HCC in patients with NAFLD

Type 2 diabetes was an independent predictor of hepatic decompensation and development of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease, according to data.

News
July 06, 2023
2 min read
Save

Treating hepatitis C ‘feasible’ in patients with HCC, improves overall survival

Treating hepatitis C ‘feasible’ in patients with HCC, improves overall survival

Failure to achieve sustained virological response and the presence of more advanced chronic liver disease were associated with mortality in patients with hepatitis C and hepatocellular carcinoma, according to a researcher at EASL Congress.

View more